Williams Andrew M
In this database
11
2018 – 2026
DB Citations
57
across indexed articles
h-index
—
Not available
Total Citations
—
Not available
11 articles in Glaucoma Journal Club
Effect of a Patient Portal Reminder Message After No-Show on Appointment Reattendance in Ophthalmology: A Randomized Clinical Trial.
EHR-based reminder messages sent within a business day of a missed appointment may promote re-engagement in ophthalmology care after appointment no-show.
Barriers to Care Among Glaucoma Patients With a Missed Appointment and Interest in a Navigator Program.
Glaucoma patients with missed appointments report barriers to care and face social risk factors.
Predictors of Clinic Attendance After Community-Based Vision Screening.
Half of the referred patients followed up after vision screening.
Factors Associated with Nonreturn after Loss to Follow-Up from Glaucoma Care: An IRIS® Registry Retrospective Analysis.
Half of patients with POAG in the IRIS Registry had at least 1 period of LTFU, and two thirds of LTFU patients with POAG did not return to care.
Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma.
An adherence-enhancing behavioral intervention was effective and cost saving at 6 months.
Loss to Follow-up and Risk of Incident Blindness among Patients with Glaucoma in the IRIS® Registry.
Loss to follow-up is an independent risk factor for incident blindness among patients with POAG.
Topiramate-Induced Angle Closure.
Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma.
From a VA payer perspective over a lifetime, the glaucoma medication-enhancing behavioral intervention dominated standard of care in terms of generating cost savings and greater QALYs.
Patient-Portal Messages Reengage Glaucoma Patients after Loss to Follow-Up.
Glaucoma Knowledge and Disease Severity in a Veteran Population: The Medication Adherence in Glaucoma to Improve Care (MAGIC) Study.
There was no difference in level of glaucoma knowledge based on disease severity.
A Woman With Bilateral Visual Field Defects.